GAMMA Investing’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$196K Buy
9,927
+724
+8% +$14.9K 0.01% 1334
2026
Q2
$180K Sell
9,203
-844
-8% -$16.7K 0.01% 1347
2026
Q1
$193K Buy
10,047
+639
+7% +$12.6K 0.01% 1148
2025
Q4
$178K Buy
9,408
+98
+1% +$1.82K 0.01% 1123
2025
Q3
$174K Buy
9,310
+2,436
+35% +$45.5K 0.01% 1077
2025
Q2
$127K Buy
6,874
+1,525
+29% +$27.1K 0.01% 1252
2025
Q1
$93.4K Buy
5,349
+187
+4% +$3.15K 0.01% 1317
2024
Q4
$89.4K Buy
5,162
+548
+12% +$10K 0.01% 1196
2024
Q3
$85.9K Buy
4,614
+932
+25% +$15.7K 0.01% 1094
2024
Q2
$56.7K Buy
3,682
+1,052
+40% +$15K 0.01% 1111
2024
Q1
$38.8K Buy
2,630
+168
+7% +$2.33K 0.01% 1198
2023
Q4
$32.8K Buy
+2,462
New +$35K 0.01% 1180

Other funds holding SBRA

GAMMA Investing's SBRA Position: Q3 2026 in Review

GAMMA Investing increased its Sabra Healthcare REIT (SBRA) stake by 7.9% in Q3 2026, buying an estimated $14.9K and bringing the position to 9,927 shares worth $196K. The position accounts for 0.01% of the portfolio, ranked #1334.

GAMMA Investing first reported a position in SBRA in Q4 2023 and has held it in 12 quarters since. 17 funds tracked by Wall St. Rank hold SBRA as of Q3 2026.

  • GAMMA Investing held 9,927 shares of Sabra Healthcare REIT worth $196K as of Q3 2026.
  • GAMMA Investing bought 724 Sabra Healthcare REIT shares in Q3 2026, an estimated $14.9K.
  • Sabra Healthcare REIT made up 0.01% of GAMMA Investing's portfolio in Q3 2026, its #1334 holding.
  • GAMMA Investing first reported a position in Sabra Healthcare REIT in Q4 2023 and has held it in 12 quarters since.
  • 17 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.